Literature DB >> 10435052

Investigation protocol: acromegaly and its investigation.

E Duncan1, J A Wass.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10435052     DOI: 10.1046/j.1365-2265.1999.00615.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  16 in total

1.  Basal and glucose-suppressed GH levels less than 1 microg/L in newly diagnosed acromegaly.

Authors:  Pamela U Freda; Carlos M Reyes; Abu T Nuruzzaman; Robert E Sundeen; Jeffrey N Bruce
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

Review 2.  Growth hormone and its disorders.

Authors:  J Ayuk; M C Sheppard
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

3.  Is GH nadir during OGTT a reliable test for diagnosis of acromegaly in patients with abnormal glucose metabolism?

Authors:  Georgiana Dobri; Soamsiri Niwattisaiwong; James F Bena; Manjula Gupta; John Kirwan; Lawrence Kennedy; Amir H Hamrahian
Journal:  Endocrine       Date:  2018-11-10       Impact factor: 3.633

4.  Psychosocial morbidity in acromegaly: a study from India.

Authors:  Surendra Kumar Mattoo; Anil Kumar Bhansali; Nitin Gupta; Sandeep Grover; Ramma Malhotra
Journal:  Endocrine       Date:  2008-10-25       Impact factor: 3.633

5.  Three-hour spontaneous GH secretion profile is as reliable as oral glucose tolerance test for the diagnosis of acromegaly.

Authors:  S Grottoli; P Razzore; D Gaia; M Gasperi; M Giusti; A Colao; E Ciccarelli; V Gasco; E Martino; E Ghigo; F Camanni
Journal:  J Endocrinol Invest       Date:  2003-02       Impact factor: 4.256

Review 6.  Pitfalls in the biochemical assessment of acromegaly.

Authors:  Pamela U Freda
Journal:  Pituitary       Date:  2003       Impact factor: 4.107

7.  Gender and age in the biochemical assessment of cure of acromegaly.

Authors:  P U Freda; R E Landman; R E Sundeen; K D Post
Journal:  Pituitary       Date:  2001-08       Impact factor: 4.107

Review 8.  Current diagnosis of acromegaly.

Authors:  Rocio A Cordero; Ariel L Barkan
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

Review 9.  Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant?

Authors:  Pamela U Freda
Journal:  Clin Endocrinol (Oxf)       Date:  2009-02-18       Impact factor: 3.478

Review 10.  Discordance between growth hormone and insulin-like growth factor-1 after pituitary surgery for acromegaly: a stepwise approach and management.

Authors:  Mehdi Zeinalizadeh; Zohreh Habibi; Juan C Fernandez-Miranda; Paul A Gardner; Steven P Hodak; Sue M Challinor
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.